Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Bode

Showing results (321-330 of 339) with videos related to

Pageof 34
Sort By:
Stem Cell Research|May 6, 2014
ERK1 phosphorylates Nanog to regulate protein stability and stem cell self-renewalSung-Hyun Kim, Myoung Ok Kim, Yong-Yeon Cho, et al.
Journal of Molecular Biology|November 13, 2012
Structural and functional analysis of the natural JNK1 inhibitor quercetagetinSohee Baek, Nam Joo Kang, Grzegorz M Popowicz, et al.
Theranostics|May 4, 2018
Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapyZheqiong Tan, Lanbo Xiao, Min Tang, et al.
Carcinogenesis|September 11, 2012
Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora BXiang Li, Haitao Li, Shengqing Li, et al.
Carcinogenesis|October 15, 2015
The retinoic acid derivative, ABPN, inhibits pancreatic cancer through induction of Nrdp1Sanguine Byun, Seung Ho Shin, Eunjung Lee, et al.
Molecular Oncology|February 22, 2018
IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancerJiang-Jiang Li, Ruilei Li, Wenxiang Wang, et al.
Carcinogenesis|November 28, 2013
[6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2Myoung Ok Kim, Mee-Hyun Lee, Naomi Oi, et al.
Theranostics|August 22, 2018
Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancerJiangjiang Li, Ya He, Zheqiong Tan, et al.
Cell Death & Disease|April 12, 2022
CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinomaMin Tang, Xin Dong, Lanbo Xiao, et al.
Molecular Carcinogenesis|April 5, 2014
Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signalingKangdong Liu, Chanmi Park, Hanyong Chen, et al.
Pageof 34

Showing results (321-330 of 339) with videos related to

Sort By:
Pageof 34
Stem Cell Research|May 6, 2014
ERK1 phosphorylates Nanog to regulate protein stability and stem cell self-renewalSung-Hyun Kim, Myoung Ok Kim, Yong-Yeon Cho, et al.
Journal of Molecular Biology|November 13, 2012
Structural and functional analysis of the natural JNK1 inhibitor quercetagetinSohee Baek, Nam Joo Kang, Grzegorz M Popowicz, et al.
Theranostics|May 4, 2018
Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapyZheqiong Tan, Lanbo Xiao, Min Tang, et al.
Carcinogenesis|September 11, 2012
Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora BXiang Li, Haitao Li, Shengqing Li, et al.
Carcinogenesis|October 15, 2015
The retinoic acid derivative, ABPN, inhibits pancreatic cancer through induction of Nrdp1Sanguine Byun, Seung Ho Shin, Eunjung Lee, et al.
Molecular Oncology|February 22, 2018
IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancerJiang-Jiang Li, Ruilei Li, Wenxiang Wang, et al.
Carcinogenesis|November 28, 2013
[6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2Myoung Ok Kim, Mee-Hyun Lee, Naomi Oi, et al.
Theranostics|August 22, 2018
Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancerJiangjiang Li, Ya He, Zheqiong Tan, et al.
Cell Death & Disease|April 12, 2022
CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinomaMin Tang, Xin Dong, Lanbo Xiao, et al.
Molecular Carcinogenesis|April 5, 2014
Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signalingKangdong Liu, Chanmi Park, Hanyong Chen, et al.
Pageof 34